Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | SGMS2 | Q8NHU3 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | RXRA | P19793 | 1/20 | 0.40 |
| ▸ | RXRB | P28702 | 1/20 | 0.40 |
| ▸ | RXRG | P48443 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.40 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | CDK4 | P11802 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28038432 | 1.00 | ALOX15 (0.44) | ALOX15SGMS2KDM4ECYP1A2ALDH1A1 | |
| SCHEMBL27808425 | 0.88 | SMN1; SMN2 (0.41) | SGMS2CYP1A2ALDH1A1MAPTLMNA | |
| SCHEMBL1200636 | 0.88 | SMN1; SMN2 (0.41) | SGMS2CYP1A2ALDH1A1MAPTLMNA | |
| SCHEMBL15375379 | 0.87 | SGMS2 (0.38) | SGMS2KDM4ECYP1A2ALDH1A1MAPT | |
| SCHEMBL9667361 | 0.87 | L3MBTL1 (0.42) | SGMS2CYP1A2ALDH1A1MAPTLMNA | |
| SCHEMBL27940440 | 0.87 | L3MBTL1 (0.42) | SGMS2CYP1A2ALDH1A1MAPTLMNA | |
| SCHEMBL15375461 | 0.86 | MAPT (0.46) | SGMS2KDM4ECYP1A2ALDH1A1MAPT | |
| SCHEMBL15375561 | 0.86 | TSHR (0.42) | SGMS2CYP1A2MAPTLMNAKMT2A | |
| SCHEMBL15375445 | 0.86 | NISCH (0.43) | SGMS2KDM4ECYP1A2ALDH1A1LMNA | |
| SCHEMBL28038431 | 0.86 | TSHR (0.42) | SGMS2CYP1A2MAPTLMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2325161-B1 | METHOD FOR PRODUCING ALPHA-HYDROXYESTER COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2018-07-25 | — | — | EP | disclosed |
| EP-2682382-B1 | Method for Producing Phenylacetamide Compound | SUMITOMO CHEMICAL CO (JP) | 2016-11-23 | — | — | EP | disclosed |
| EP-2662352-B1 | Method for Producing Phenylacetamide Compound | SUMITOMO CHEMICAL CO (JP) | 2016-11-09 | — | — | EP | disclosed |
| CN-102131761-B | Process for producing alpha-hydroxy ester compound | 住友化学株式会社 | 2016-09-28 | — | — | CN | disclosed |
| EP-2397459-B1 | METHOD FOR PRODUCING PHENYLACETAMIDE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2015-12-16 | — | — | EP | disclosed |
| CN-103641731-B | The manufacture method of phenylacetyl amine compound | SUMITOMO CHEMICAL CO., LTD. (JP) | 2015-10-28 | — | — | CN | disclosed |
| EP-2682382-A2 | Method for Producing Phenylacetamide Compound | Sumitomo Chemical Company, Limited (JP) | 2014-01-08 | — | — | EP | disclosed |
| US-8624062-B2 | Method for producing phenylacetamide compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-01-07 | — | — | US | disclosed |
| EP-2662352-A2 | Method for Producing Phenylacetamide Compound | Sumitomo Chemical Company, Limited (JP) | 2013-11-13 | — | — | EP | disclosed |
| US-8299288-B2 | Method for producing α-hydroxyester compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-30 | — | — | US | disclosed |
| EP-2397459-A1 | METHOD FOR PRODUCING PHENYLACETAMIDE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2011-12-21 | — | — | EP | disclosed |
| US-20110295035-A1 | METHOD FOR PRODUCING PHENYLACETAMIDE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-01 | — | — | US | disclosed |
| US-20110144372-A1 | METHOD FOR PRODUCING a-HYDROXYESTER COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-06-16 | — | — | US | disclosed |
| EP-2325161-A1 | METHOD FOR PRODUCING -HYDROXYESTER COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2011-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144372-A1 | METHOD FOR PRODUCING a-HYDROXYESTER COMPOUND | CYP17A1, CYP21A2, HSD11B2 | ALOX15 230/4885SGMS2 637/4885KDM4E 3286/4885 |
| US-20110295035-A1 | METHOD FOR PRODUCING PHENYLACETAMIDE COMPOUND | MRPL21, AADAC, ARSA | ALOX15 4801/4885SGMS2 1658/4885KDM4E 2619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.